CVS Health Corp (CVS) : Gillespie Robinson Grimm Inc reduced its stake in CVS Health Corp by 2.87% during the most recent quarter end. The investment management company now holds a total of 282,855 shares of CVS Health Corp which is valued at $28,692,811 after selling 8,370 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on Apr 18, 2016.CVS Health Corp makes up approximately 4.56% of Gillespie Robinson Grimm Inc’s portfolio.
CVS Health Corp opened for trading at $101.33 and hit $101.62 on the upside on Friday, eventually ending the session at $101.44, with a gain of 0.22% or 0.22 points. The heightened volatility saw the trading volume jump to 26,52,421 shares. Company has a market cap of $111,431 M.
Other Hedge Funds, Including , Joel Isaacson boosted its stake in CVS in the latest quarter, The investment management firm added 295 additional shares and now holds a total of 44,803 shares of CVS Health Corp which is valued at $4,544,816. CVS Health Corp makes up approx 0.99% of Joel Isaacson’s portfolio.Campbell Newman Asset Management Inc boosted its stake in CVS in the latest quarter, The investment management firm added 7,013 additional shares and now holds a total of 163,465 shares of CVS Health Corp which is valued at $16,712,662. CVS Health Corp makes up approx 3.43% of Campbell Newman Asset Management Inc’s portfolio.E&g Advisors Lp boosted its stake in CVS in the latest quarter, The investment management firm added 1,070 additional shares and now holds a total of 11,170 shares of CVS Health Corp which is valued at $1,142,021. CVS Health Corp makes up approx 0.74% of E&g Advisors Lp’s portfolio.Daiwa Sb Investments Ltd. reduced its stake in CVS by selling 3,359 shares or 20.08% in the most recent quarter. The Hedge Fund company now holds 13,370 shares of CVS which is valued at $1,366,949. CVS Health Corp makes up approx 0.34% of Daiwa Sb Investments Ltd.’s portfolio.
On the company’s financial health, CVS Health Corp reported $1.53 EPS for the quarter, based on the information available during the earnings call on Feb 9, 2016. Analyst had a consensus estimate of $1.53. The company had revenue of $41145.00 million for the quarter, compared to analysts expectations of $41126.27 million. The company’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.21 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Shares were Reiterated by Mizuho on Feb 10, 2016 to “Buy” and Lowered the Price Target to $ 104 from a previous price target of $113 .CVS Health Corp was Initiated by Atlantic Equities to “Overweight” on Feb 3, 2016.
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.